IDEAS home Printed from https://ideas.repec.org/f/pde347.html
   My authors  Follow this author

Nancy Devlin

Personal Details

First Name:Nancy
Middle Name:Joy
Last Name:Devlin
Suffix:
RePEc Short-ID:pde347
https://www.linkedin.com/in/nancy-devlin-595b1b18
PO Box 694 Wānaka 9343 New Zealand
++64 204219622

Affiliation

(47%) Centre for Health Policy
University of Melbourne

Melbourne, Australia
http://mspgh.unimelb.edu.au/research-groups/centre-for-health-policy
RePEc:edi:chmelau (more details at EDIRC)

(47%) Health Economics and Decision Science (HEDS)
School of Health and Related Research (ScHARR)
University of Sheffield

Sheffield, United Kingdom
http://www.sheffield.ac.uk/heds
RePEc:edi:hesheuk (more details at EDIRC)

(6%) Office of Health Economics

London, United Kingdom
http://www.ohe.org/
RePEc:edi:ohecouk (more details at EDIRC)

Research output

as
Jump to: Working papers Articles Books

Working papers

  1. Sampson, C. & Parkin, D. & Devlin, N., 2020. "Drop Dead: Is Anchoring at 'Dead' a Theoretical Requirement in Health State Valuation?," Research Papers 002308, Office of Health Economics.
  2. Shah, K.K & Ramos-Goñi, J.M & Kreimeier, S. & Devlin, N.J, 2020. "Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead," Research Papers 002235, Office of Health Economics.
  3. Hampson, G. & Mott, D. & Devlin, N. & Shah, K., 2019. "Public Preferences for Health Gains and Cures: A Discrete Choice Experiment," Consulting Reports 002108, Office of Health Economics.
  4. Mott, D.J & Shah, K.K & Ramos-Goñi, J.M & Devlin, N.J & Rivero-Arias, O., 2019. "Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?," Research Papers 002184, Office of Health Economics.
  5. Devlin, N. & Lorgelly, P. & Herdman, M., 2019. "Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA," Research Papers 002094, Office of Health Economics.
  6. Hernandez-Villafuerte, K. & Zamora, B. & Feng, Y. & Parkin, D. & Devlin, N. & Towse, A., 2019. "Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England," Research Papers 002142, Office of Health Economics.
  7. Zamora, B. & Parkin, D. & Feng, Y. & Bateman, A. & Herdman, M. & Devlin, N., 2018. "New Methods for Analysing the Distribution of EQ-5D Observations," Research Papers 001984, Office of Health Economics.
  8. Cubi-Molla, P. & Mott, D. & Shah, K. & Herdman, M. & Summers, Y. & Devlin, N., 2018. "Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology," Consulting Reports 002023, Office of Health Economics.
  9. Mulhern, B. & Feng, Y. & Shah, K. & van Hout, B. & Janssen, B. & Herdman, M. & Devlin, N., 2017. "Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets," Research Papers 001821, Office of Health Economics.
  10. Cubi-Molla, P. & Shah, K.K & Garside, J. & Herdman, M. & Devlin, N., 2017. "Age and Utilities: Issues for HTA," Research Papers 001830, Office of Health Economics.
  11. Devlin, N. & Shah, K.K & Buckingham, K., 2017. "What is the Normative Basis for Selecting the Measure of 'Average' Preferences for Use in Social Choices?," Research Papers 001798, Office of Health Economics.
  12. Devlin, N. & Shah, K. & Mulhern, B. & Pantiri, K. & van Hout, B., 2017. "A New Valuation Method: Directly Eliciting Personal Utility Functions," Research Papers 001885, Office of Health Economics.
  13. Feng, Y. & Devlin, N. & Shah, K. & Mulhern, B. & Van Hout, B., 2016. "New Methods for Modelling EQ-5D-5L Value Sets: An Application to English Data," Research Papers 001679, Office of Health Economics.
  14. Feng, Y. & Devlin, N. & Bateman, A. & Zamora, B. & Parkin, D., 2016. "The Distribution of the EQ-5D-5L Index in Patient Populations," Research Papers 001756, Office of Health Economics.
  15. Karlsberg Schaffer, S. & Cubi-Molla, P. & Devlin, N. & Towse, A., 2016. "Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making," Consulting Reports 001699, Office of Health Economics.
  16. O'Neill, P. & Cole, A. & Duran, A. & Devlin, N., 2016. "An Analysis of NICE Technology Appraisal Decisions 'Recommended in Line with Clinical Practice'," Research Papers 001777, Office of Health Economics.
  17. Cole, A. & Marsden, G. & Devlin, N. & Grainger, D. & Lee, E.K & Oortwijn, W., 2016. ""New Age" Decision Making in HTA: Is It Applicable in Asia?," Briefings 001741, Office of Health Economics.
  18. Devlin, N. & Shah, K. & Feng, Y. & Mulhern, B. & Van Hout, B., 2016. "Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England," Research Papers 001678, Office of Health Economics.
  19. Brockis, E. & Marsden, G. & Cole, A. & Devlin, N., 2016. "A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications," Research Papers 001703, Office of Health Economics.
  20. Garau, M. & Marsden, G. & Devlin, N. & Amedeo Mazzanti, N. & Profico, A., 2016. "Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders' Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)," Research Papers 001773, Office of Health Economics.
  21. Shah, K. & Chapman, A. & Devlin, N. & Barnsley, P., 2015. "Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?," Consulting Reports 001576, Office of Health Economics.
  22. Papadimitropoulos, M. & Elbarazi, I. & Blair, I. & Katsaiti, M.S & Shah, K. & Devlin, N., 2015. "An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate EQ-5D-5L Values in the United Arab Emirates," Research Papers 001582, Office of Health Economics.
  23. Parkin, D. & Devlin, N. & Feng, Y., 2014. "What Determines the Shape of an EQ-5D Index Distribution?," Research Papers 000530, Office of Health Economics.
  24. Karlsberg Schaffer, S. & Sussex, J. & Hughes, D. & Devlin, N., 2014. "Opportunity Costs of Implementing NICE Decisions in NHS Wales," Research Papers 000517, Office of Health Economics.
  25. Karlsberg Schaffer, S. & Sussex, J. & Devlin, N. & Walker, A., 2013. "Searching for Cost-effectiveness Thresholds in NHS Scotland," Research Papers 000078, Office of Health Economics.
  26. Helen Dakin & Nancy Devlin & Yan Feng & Nigel Rice & Phill O’Neill & David Parkin, 2013. "The influence of cost-effectiveness and other factors on NICE decisions," Working Papers 093cherp, Centre for Health Economics, University of York.
  27. Cubi-Molla, P. & de Vries, J. & Devlin, N., 2013. "A Study of the Relationship Between Health and Subjective Well-being in Parkinson's Disease Patients," Research Papers 000108, Office of Health Economics.
  28. Karl Claxton & Steve Martin & Marta Soares & Nigel Rice & Eldon Spackman & Sebastian Hinde & Nancy Devlin & Peter C Smith & Mark Sculpher, 2013. "Methods for the estimation of the NICE cost effectiveness threshold," Working Papers 081cherp, Centre for Health Economics, University of York.
  29. Nils Gutacker & Chris Bojke & Silvio Daidone & Nancy Devlin & Andrew Street, 2012. "Analysing Hospital Variation in Health Outcome at the Level of EQ-5D Dimensions," Working Papers 074cherp, Centre for Health Economics, University of York.
  30. Feng, Y. & Parkin, D. & Devlin, N., 2012. "Assessing the Performance of the EQ-VAS in the NHS PROMs Programme," Research Papers 000165, Office of Health Economics.
  31. Shah, K. & Devlin, N., 2012. "Understanding Social Preferences Regarding the Prioritisation of Treatments Addressing Unmet Need and Severity," Research Papers 000126, Office of Health Economics.
  32. O'Neill, P. & Devlin, N. & Puig-Peiro, R., 2012. "Time Trends in NICE HTA Decisions," Consulting Reports 000169, Office of Health Economics.
  33. Versteegh, MM & Attema, AE & Oppe, M & Devlin, NJ & Stolk, EA, 2012. "Time to tweak the TTO. But how?," MPRA Paper 37989, University Library of Munich, Germany.
  34. Nils Gutacker & Chris Bojke & Silvio Daidone & Nancy Devlin & David Parkin & Andrew Street, 2011. "Truly inefficient or providing better quality of care? Analysing the relationship between riskadjusted hospital costs and patients’ health outcomes," Working Papers 068cherp, Centre for Health Economics, University of York.
  35. Towse, A. & Devlin, N. & Hawe, E. & Garrison, L., 2011. "The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response," Consulting Reports 000192, Office of Health Economics.
  36. Sussex, J. & Towse, A. & Devlin, N., 2011. "Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches," Research Papers 000177, Office of Health Economics.
  37. Shah, K. & Praet, C. & Devlin, N. & Sussex, J. & Appleby, J. & Parkin, D., 2011. "Is the Aim of the Health Care System to Maximise QALYs? An Investigation of," Research Papers 000180, Office of Health Economics.
  38. Devlin, N. & Buckingham, K. & Shah, K. & Tsuchiya, A. & Tilling, C. & Wilkinson, G. & van Hout, B., 2010. "A Comparison of Alternative Variants of the Lead and Lag Time TTO," Research Papers 000194, Office of Health Economics.
  39. Devlin, N. & Tsuchiya, A. & Buckingham, K. & Tilling, C., 2009. "Does the value of quality of life depend on duration?," Working Papers 09/07, Department of Economics, City University London.
  40. Devlin, N. & Tsuchiya, A. & Buckingham, K. & Tilling, C., 2009. "A uniform Time Trade Off method for states better and worse than dead: feasibility study of the ‘lead time’ approach," Working Papers 09/08, Department of Economics, City University London.
  41. Devlin, N. & Parkin, D. & Browne, J., 2009. "Using the EQ-5D as a performance measurement tool in the NHS," Working Papers 09/03, Department of Economics, City University London.
  42. Buckingham, K. & Devlin, N., 2008. "A note on the nature of utility in time and health and implications for cost utility analysis," Working Papers 08/02, Department of Economics, City University London.
  43. Parkin, D. & Rice, N. & Devlin, N., 2008. "Statistical analysis of EQ-5D profiles: does the use of value sets bias inference?," Working Papers 08/10, Department of Economics, City University London.
  44. Dimakou, S. & Parkin, D. & Devlin, N. & Appleby, J., 2006. "The impact of government targets on waiting times for elective surgery: new insights from time-to-event analysis," Working Papers 06/05, Department of Economics, City University London.
  45. Sadique, Z. & Edmunds, W. J. & Devlin, N. & Parkin, D., 2005. "Understanding individuals’ decisions about vaccination: a comparison between Expected Utility and Regret Theory models," Working Papers 05/03, Department of Economics, City University London.
  46. Buckingham, K. & Devlin, N. & Tabberer, M., 2004. "A theoretical framework for TTO valuations and a taxonomy of TTO approaches: results from a pilot study," Working Papers 04/07, Department of Economics, City University London.
  47. Parkin, D. & Devlin, N., 2004. "Is there a case for using Visual Analogue Scale valuations in Cost-Utility Analysis?," Working Papers 04/03, Department of Economics, City University London.
  48. Devlin, N., 2003. "Does NICE have a cost effectiveness threshold and what other factors influence its decisions? A discrete choice analysis," Working Papers 03/01, Department of Economics, City University London.
  49. N J Devlin & P Hansen & P Kind & A H Williams, 2000. "The health state preferences and logistical inconsistencies of New Zealanders: a tale of two tariffs," Working Papers 180chedp, Centre for Health Economics, University of York.
  50. Nancy Devlin & Paul Hansen, 2000. "Allocating Vote: Health — ‘Needs Assessment’ and an Economics-Based Approach," Treasury Working Paper Series 00/04, New Zealand Treasury.

Articles

  1. Tianxin Pan & Brendan Mulhern & Rosalie Viney & Richard Norman & Janel Hanmer & Nancy Devlin, 2022. "A Comparison of PROPr and EQ-5D-5L Value Sets," PharmacoEconomics, Springer, vol. 40(3), pages 297-307, March.
  2. Cate Bailey & Martin Howell & Rakhee Raghunandan & Amber Salisbury & Gang Chen & Joanna Coast & Jonathan C. Craig & Nancy J. Devlin & Elisabeth Huynh & Emily Lancsar & Brendan J. Mulhern & Richard Nor, 2022. "Preference Elicitation Techniques Used in Valuing Children’s Health-Related Quality-of-Life: A Systematic Review," PharmacoEconomics, Springer, vol. 40(7), pages 663-698, July.
  3. Joseph Kwon & Louise Freijser & Elisabeth Huynh & Martin Howell & Gang Chen & Kamran Khan & Shahd Daher & Nia Roberts & Conrad Harrison & Sarah Smith & Nancy Devlin & Kirsten Howard & Emily Lancsar & , 2022. "Correction to: Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures," PharmacoEconomics, Springer, vol. 40(4), pages 477-478, April.
  4. Joseph Kwon & Louise Freijser & Elisabeth Huynh & Martin Howell & Gang Chen & Kamran Khan & Shahd Daher & Nia Roberts & Conrad Harrison & Sarah Smith & Nancy Devlin & Kirsten Howard & Emily Lancsar & , 2022. "Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures," PharmacoEconomics, Springer, vol. 40(4), pages 379-431, April.
  5. Cate Bailey & Kim Dalziel & Paula Cronin & Nancy Devlin & Rosalie Viney, 2022. "How are Child-Specific Utility Instruments Used in Decision Making in Australia? A Review of Pharmaceutical Benefits Advisory Committee Public Summary Documents," PharmacoEconomics, Springer, vol. 40(2), pages 157-182, February.
  6. David J. Mott & Koonal K. Shah & Juan Manuel Ramos-Goñi & Nancy J. Devlin & Oliver Rivero-Arias, 2021. "Valuing EQ-5D-Y-3L Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?," Medical Decision Making, , vol. 41(5), pages 584-596, July.
  7. Tessa Peasgood & Clara Mukuria & Jill Carlton & Janice Connell & Nancy Devlin & Karen Jones & Rosemary Lovett & Bhash Naidoo & Stacey Rand & Juan Carlos Rejon-Parrilla & Donna Rowen & Aki Tsuchiya & J, 2021. "What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the dev," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(7), pages 1067-1081, September.
  8. Richard De Abreu Lourenço & Nancy Devlin & Kirsten Howard & Jason J. Ong & Julie Ratcliffe & Jo Watson & Esther Willing & Elisabeth Huynh, 2021. "Giving a Voice to Marginalised Groups for Health Care Decision Making," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 14(1), pages 5-10, January.
  9. Patricia Cubi-Molla & Martin Buxton & Nancy Devlin, 2021. "Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?," Applied Health Economics and Health Policy, Springer, vol. 19(5), pages 635-644, September.
  10. Andrew J. Palmer & Julie A. Campbell & Barbara de Graaff & Nancy Devlin & Hasnat Ahmad & Philip M Clarke & Mingsheng Chen & Lei Si, 2021. "Population norms for quality adjusted life years for the United States of America, China, the United Kingdom and Australia," Health Economics, John Wiley & Sons, Ltd., vol. 30(8), pages 1950-1977, August.
  11. Cristina Gutierrez-Delgado & Rosa-María Galindo-Suárez & Cesar Cruz-Santiago & Koonal Shah & Manny Papadimitropoulos & Yan Feng & Bernarda Zamora & Nancy Devlin, 2021. "EQ-5D-5L Health-State Values for the Mexican Population," Applied Health Economics and Health Policy, Springer, vol. 19(6), pages 905-914, November.
  12. Zhang, Angela & Prang, Khic-Houy & Devlin, Nancy & Scott, Anthony & Kelaher, Margaret, 2020. "The impact of price transparency on consumers and providers: A scoping review," Health Policy, Elsevier, vol. 124(8), pages 819-825.
  13. Koonal K. Shah & Juan Manuel Ramos-Goñi & Simone Kreimeier & Nancy J. Devlin, 2020. "An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(7), pages 1091-1103, September.
  14. Juan M. Ramos-Goñi & Mark Oppe & Elly Stolk & Koonal Shah & Simone Kreimeier & Oliver Rivero-Arias & Nancy Devlin, 2020. "International Valuation Protocol for the EQ-5D-Y-3L," PharmacoEconomics, Springer, vol. 38(7), pages 653-663, July.
  15. Sullivan, Trudy & Hansen, Paul & Ombler, Franz & Derrett, Sarah & Devlin, Nancy, 2020. "A new tool for creating personal and social EQ-5D-5L value sets, including valuing ‘dead’," Social Science & Medicine, Elsevier, vol. 246(C).
  16. Donna Rowen & Oliver Rivero-Arias & Nancy Devlin & Julie Ratcliffe, 2020. "Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?," PharmacoEconomics, Springer, vol. 38(4), pages 325-340, April.
  17. Hobbins, Anna P. & Barry, Luke & Kelleher, Dan & Shah, Koonal & Devlin, Nancy & Ramos Goni, Juan Manuel & O’Neill, Ciaran, 2020. "Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland," Health Policy, Elsevier, vol. 124(6), pages 639-646.
  18. Nancy J. Devlin & Koonal K. Shah & Brendan J. Mulhern & Krystallia Pantiri & Ben van Hout, 2019. "A new method for valuing health: directly eliciting personal utility functions," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(2), pages 257-270, March.
  19. Nancy J. Devlin, 2019. "All Male Panels and Other Diversity Considerations for ISPOR," PharmacoEconomics - Open, Springer, vol. 3(3), pages 423-426, September.
  20. Fan Yang & Nancy Devlin & Nan Luo, 2019. "Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(1), pages 99-105, February.
  21. Brendan Mulhern & Yan Feng & Koonal Shah & Mathieu F. Janssen & Michael Herdman & Ben Hout & Nancy Devlin, 2018. "Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets," PharmacoEconomics, Springer, vol. 36(6), pages 699-713, June.
  22. Nancy Devlin & John Brazier & A. Simon Pickard & Elly Stolk, 2018. "Correction to: 3L, 5L, What the L? A NICE Conundrum," PharmacoEconomics, Springer, vol. 36(6), pages 729-729, June.
  23. Anna Hobbins & Luke Barry & Dan Kelleher & Koonal Shah & Nancy Devlin & Juan Manuel Ramos Goni & Ciaran O’Neill, 2018. "Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L," PharmacoEconomics, Springer, vol. 36(11), pages 1345-1353, November.
  24. Nancy Devlin & John Brazier & A. Simon Pickard & Elly Stolk, 2018. "3L, 5L, What the L? A NICE Conundrum," PharmacoEconomics, Springer, vol. 36(6), pages 637-640, June.
  25. Brendan Mulhern & Yan Feng & Koonal Shah & Mathieu F. Janssen & Michael Herdman & Ben Hout & Nancy Devlin, 2018. "Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets," PharmacoEconomics, Springer, vol. 36(6), pages 727-727, June.
  26. Yan Feng & Nancy J. Devlin & Koonal K. Shah & Brendan Mulhern & Ben van Hout, 2018. "New methods for modelling EQ‐5D‐5L value sets: An application to English data," Health Economics, John Wiley & Sons, Ltd., vol. 27(1), pages 23-38, January.
  27. Martina Garau & Grace Hampson & Nancy Devlin & Nicola Amedeo Mazzanti & Antonio Profico, 2018. "Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)," PharmacoEconomics - Open, Springer, vol. 2(2), pages 153-163, June.
  28. Nancy J. Devlin & Koonal K. Shah & Yan Feng & Brendan Mulhern & Ben van Hout, 2018. "Valuing health‐related quality of life: An EQ‐5D‐5L value set for England," Health Economics, John Wiley & Sons, Ltd., vol. 27(1), pages 7-22, January.
  29. Amanda Cole & Koonal Shah & Brendan Mulhern & Yan Feng & Nancy Devlin, 2018. "Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(4), pages 595-605, May.
  30. Paul F. M. Krabbe & Elly A. Stolk & Nancy J. Devlin & Feng Xie & Elise H. Quik & A. Simon Pickard, 2017. "Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(8), pages 967-977, November.
  31. Emma Cowles & Grace Marsden & Amanda Cole & Nancy Devlin, 2017. "A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact?," Applied Health Economics and Health Policy, Springer, vol. 15(4), pages 469-477, August.
  32. Nancy J. Devlin & Richard Brooks, 2017. "EQ-5D and the EuroQol Group: Past, Present and Future," Applied Health Economics and Health Policy, Springer, vol. 15(2), pages 127-137, April.
  33. Mike Herdman & Jameel Nazir & Zalmai Hakimi & Emad Siddiqui & Moses Huang & Marco Pavesi & Scott MacDiarmid & Marcus J. Drake & Nancy Devlin, 2017. "Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 10(6), pages 677-686, December.
  34. David Parkin & Nancy Devlin & Yan Feng, 2016. "What Determines the Shape of an EQ-5D Index Distribution?," Medical Decision Making, , vol. 36(8), pages 941-951, November.
  35. Helen Dakin & Nancy Devlin & Yan Feng & Nigel Rice & Phill O'Neill & David Parkin, 2015. "The Influence of Cost‐Effectiveness and Other Factors on Nice Decisions," Health Economics, John Wiley & Sons, Ltd., vol. 24(10), pages 1256-1271, October.
  36. Feng Xie & A. Pickard & Paul Krabbe & Dennis Revicki & Rosalie Viney & Nancy Devlin & David Feeny, 2015. "A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE)," PharmacoEconomics, Springer, vol. 33(8), pages 867-877, August.
  37. David Nuttall & David Parkin & Nancy Devlin, 2015. "Inter‐Provider Comparison Of Patient‐Reported Outcomes: Developing An Adjustment To Account For Differences In Patient Case Mix," Health Economics, John Wiley & Sons, Ltd., vol. 24(1), pages 41-54, January.
  38. Karlsberg Schaffer, Sarah & Sussex, Jon & Devlin, Nancy & Walker, Andrew, 2015. "Local health care expenditure plans and their opportunity costs," Health Policy, Elsevier, vol. 119(9), pages 1237-1244.
  39. Nils Gutacker & Chris Bojke & Silvio Daidone & Nancy J. Devlin & David Parkin & Andrew Street, 2013. "Truly Inefficient Or Providing Better Quality Of Care? Analysing The Relationship Between Risk‐Adjusted Hospital Costs And Patients' Health Outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 22(8), pages 931-947, August.
  40. Federico Augustovski & Lucila Rey-Ares & Vilma Irazola & Mark Oppe & Nancy Devlin, 2013. "Lead versus lag-time trade-off variants: does it make any difference?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(1), pages 25-31, July.
  41. Koonal Shah & Andrew Lloyd & Mark Oppe & Nancy Devlin, 2013. "One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(1), pages 65-73, July.
  42. Matthijs Versteegh & Arthur Attema & Mark Oppe & Nancy Devlin & Elly Stolk, 2013. "Time to tweak the TTO: results from a comparison of alternative specifications of the TTO," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(1), pages 43-51, July.
  43. Nils Gutacker & Chris Bojke & Silvio Daidone & Nancy Devlin & Andrew Street, 2013. "Hospital Variation in Patient-Reported Outcomes at the Level of EQ-5D Dimensions," Medical Decision Making, , vol. 33(6), pages 804-818, August.
  44. Nan Luo & Minghui Li & Elly Stolk & Nancy Devlin, 2013. "The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(1), pages 15-24, July.
  45. Nancy Devlin & Paul Krabbe, 2013. "The development of new research methods for the valuation of EQ-5D-5L," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(1), pages 1-3, July.
  46. Nancy Devlin & Ken Buckingham & Koonal Shah & Aki Tsuchiya & Carl Tilling & Grahame Wilkinson & Ben van Hout, 2013. "A Comparison Of Alternative Variants Of The Lead And Lag Time Tto," Health Economics, John Wiley & Sons, Ltd., vol. 22(5), pages 517-532, May.
  47. Jon Sussex & Adrian Towse & Nancy Devlin, 2013. "Operationalizing Value-Based Pricing of Medicines," PharmacoEconomics, Springer, vol. 31(1), pages 1-10, January.
  48. Nancy J. Devlin & Aki Tsuchiya & Ken Buckingham & Carl Tilling, 2011. "A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach," Health Economics, John Wiley & Sons, Ltd., vol. 20(3), pages 348-361, March.
  49. Phill O’Neill & Nancy Devlin, 2010. "An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions," PharmacoEconomics, Springer, vol. 28(11), pages 987-993, November.
  50. Carl Tilling & Nancy Devlin & Aki Tsuchiya & Ken Buckingham, 2010. "Protocols for Time Tradeoff Valuations of Health States Worse than Dead: A Literature Review," Medical Decision Making, , vol. 30(5), pages 610-619, September.
  51. Nancy J. Devlin & David Parkin & John Browne, 2010. "Patient‐reported outcome measures in the NHS: new methods for analysing and reporting EQ‐5D data," Health Economics, John Wiley & Sons, Ltd., vol. 19(8), pages 886-905, August.
  52. David Parkin & Nigel Rice & Nancy Devlin, 2010. "Statistical Analysis of EQ-5D Profiles: Does the Use of Value Sets Bias Inference?," Medical Decision Making, , vol. 30(5), pages 556-565, September.
  53. Buckingham, Ken J. & Devlin, Nancy Joy, 2009. "A note on the nature of utility in time and health and implications for cost utility analysis," Social Science & Medicine, Elsevier, vol. 68(2), pages 362-367, January.
  54. Sofia Dimakou & David Parkin & Nancy Devlin & John Appleby, 2009. "Identifying the impact of government targets on waiting times in the NHS," Health Care Management Science, Springer, vol. 12(1), pages 1-10, March.
  55. Appleby, John & Devlin, Nancy & Parkin, David & Buxton, Martin & Chalkidou, Kalipso, 2009. "Searching for cost effectiveness thresholds in the NHS," Health Policy, Elsevier, vol. 91(3), pages 239-245, August.
  56. David Parkin & Nancy Devlin, 2007. "‘Is there a case for using visual analogue scale valuations in CUA? Yes there is a case, but what does it add to ordinal data?’ a rejoinder," Health Economics, John Wiley & Sons, Ltd., vol. 16(6), pages 649-651, June.
  57. David Parkin & Nancy Devlin, 2006. "Is there a case for using visual analogue scale valuations in cost‐utility analysis?," Health Economics, John Wiley & Sons, Ltd., vol. 15(7), pages 653-664, July.
  58. Dakin, Helen Angela & Devlin, Nancy J. & Odeyemi, Isaac A.O., 2006. ""Yes", "No" or "Yes, but"? Multinomial modelling of NICE decision-making," Health Policy, Elsevier, vol. 77(3), pages 352-367, August.
  59. Ken Buckingham & Nancy Devlin, 2006. "A theoretical framework for TTO valuations of health," Health Economics, John Wiley & Sons, Ltd., vol. 15(10), pages 1149-1154, October.
  60. Ashton, Toni & Mays, Nicholas & Devlin, Nancy, 2005. "Continuity through change: The rhetoric and reality of health reform in New Zealand," Social Science & Medicine, Elsevier, vol. 61(2), pages 253-262, July.
  61. Nancy Devlin & Paul Hansen & Peter Herbison & Susan Macran, 2005. "A ‘new and improved’ EQ-5D valuation questionnaire?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(1), pages 73-82, March.
  62. Nancy J. Devlin, 2004. "Getting Health Economics into Practice, Edited by David Kernick. Radcliffe Medical Press, Oxford, 2002. No. of pages: 358. ISBN 1‐85775‐575‐8," Health Economics, John Wiley & Sons, Ltd., vol. 13(5), pages 499-500, May.
  63. Nancy Devlin & David Parkin, 2004. "Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis," Health Economics, John Wiley & Sons, Ltd., vol. 13(5), pages 437-452, May.
  64. Nancy J. Devlin & Paul Hansen & Paul Kind & Alan Williams, 2003. "Logical inconsistencies in survey respondents' health state valuations ‐ a methodological challenge for estimating social tariffs," Health Economics, John Wiley & Sons, Ltd., vol. 12(7), pages 529-544, July.
  65. Nancy J. Devlin, 2002. "The Purchasing of Health Care by Primary Care Organisations. An evaluation and Guide to Future Policy, by N. Mays, S. Wyke, G. Malbon, N. Goodwin. Open University Press, Buckingham and Philadelphia, 2," Health Economics, John Wiley & Sons, Ltd., vol. 11(6), pages 567-568, September.
  66. Nancy Devlin & Paul Hansen, 2001. "Health care spending and economic output: Granger causality," Applied Economics Letters, Taylor & Francis Journals, vol. 8(8), pages 561-564.
  67. Scuffham, P. & Devlin, N. & Eberhart-Phillips, J. & Wilson-Salt, R., 1999. "The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule," Social Science & Medicine, Elsevier, vol. 49(6), pages 763-779, September.
  68. Szeto, Kam Leong & Devlin, Nancy J., 1996. "The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand," Health Policy, Elsevier, vol. 38(2), pages 101-115, November.
  69. Nancy Devlin & Paul Hansen & Stephen Knowles, 1995. "Comment: Financing New Zealand’s Tertiary Education: How Much Subsidy?," Agenda - A Journal of Policy Analysis and Reform, Australian National University, College of Business and Economics, School of Economics, vol. 2(2), pages 223-225.
  70. Devlin, N.J., 1994. "The effects of denturism: New Zealand dentists' response to competition," American Journal of Public Health, American Public Health Association, vol. 84(10), pages 1675-1677.

Books

  1. Devlin, N. & Sussex, J., 2011. "Incorporating Multiple Criteria in HTA: Methods and Processes," Monographs, Office of Health Economics, number 000189.
  2. Devlin, N. & Appleby, J., 2010. "Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making," Monographs, Office of Health Economics, number 000220.
  3. Appleby, J. Devlin, N. & Dawson, D., 2004. "How Much Should We Spend on the NHS?," Monographs, Office of Health Economics, number 000490.
  4. Towse, A. & Pritchard, C. & Devlin, N. eds, 2002. "Cost-Effectiveness Thresholds: Economic and ethical issues," Monographs, Office of Health Economics, number 000473.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Rankings

This author is among the top 5% authors according to these criteria:
  1. Number of Distinct Works
  2. Record of graduates

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 17 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HEA: Health Economics (14) 2012-03-21 2012-03-21 2013-12-15 2018-05-21 2018-05-28 2018-05-28 2018-05-28 2018-05-28 2018-05-28 2019-02-04 2019-03-25 2019-07-15 2020-01-20 2020-12-07. Author is listed
  2. NEP-UPT: Utility Models & Prospect Theory (5) 2018-05-28 2018-05-28 2018-05-28 2020-01-20 2020-12-07. Author is listed
  3. NEP-DCM: Discrete Choice Models (3) 2013-12-15 2019-02-04 2020-01-20
  4. NEP-EFF: Efficiency & Productivity (1) 2012-03-21
  5. NEP-HPE: History & Philosophy of Economics (1) 2018-05-28
  6. NEP-KNM: Knowledge Management & Knowledge Economy (1) 2018-07-09
  7. NEP-ORE: Operations Research (1) 2019-07-15

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Nancy Joy Devlin should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.